Voluntary Program for Dietary Supplements: Kava
Mar. 8, 2001
Consumer Healthcare Products Association (CHPA) members agree voluntarily to market products containing kava (Piper methysticum) with the following dosage and labeling:
- Labeled Content: Products containing kava should be formulated and labeled to limit consumption of total kavalactones to 300 mg per day.
- Labeling: Labels of all products containing kava should bear the following statements, or their substantial equivalent and where appropriate consistent with other CHPA voluntary labeling programs:
Caution: Not for use by persons under the age of 18. If pregnant, nursing a baby, or taking a prescription drug, ask a health professional prior to use. Do not exceed recommended dose. Excessive consumption may impair ability to drive or operate heavy equipment. Not recommended for consumption with alcoholic beverages.